Search Results 1271-1280 of 13315 for monoclonal antibody

1. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

2. A Study To Evaluate The Safety And Effectiveness Of Axicabtagene Ciloleucel In Combination With Rituximab In Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

   Anti-CD20 monoclonal antibody;; An anthracycline-containing chemotherapy regimen. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 ...

3. Axicabtagene Ciloleucel Expanded Access Study - Mayo Clinic

   anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative, and; an anthracycline containing chemotherapy regimen;. No evidence ...

4. A Study Of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) - Mayo Clinic

   ... antibody (including ipilimumab), or any other antibody or drug ... Known severe hypersensitivity reactions to monoclonal antibodies (Grade ≥3) ...

5. Clinical trials - Oncology (Medical)

   ... antibody) * Olaparib (a type of PARP inhibitor) ... A Study of Hematopoiesis in Patients with Monoclonal ... Monoclonal B Cell Lymphocytosis (MBL) and B ...

6. A Study Of The Effectiveness And Safety Of Mepolizumab As Adjunctive Therapy In Participants With Severe Eosinophilic Asthma - Mayo Clinic

   Participants who have received any monoclonal antibody (other than Xolair) to treat inflammatory disease within 5 half-lives of visit 1; Participants who ...

7. Phase 1a/​1b Study Of Aplitabart (IGM-8444) Alone Or In Combination In Participants With Relapsed, Refractory, Or Newly Diagnosed Cancers - Mayo Clinic

   weeks or 5 half-lives, prior to the first dose of study treatment. - Treatment with a monoclonal antibody, or any other anticancer agent (including biologic ...

8. Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients with Chronic Rhinosinusitis and Nasal Polyps - Mayo Clinic

   ... monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling. We assessed its efficacy and safety in patients with uncontrolled asthma ...

9. A Controlled Clinical Study Of Dupilumab In Patients With Nasal Polyps

   Any experimental monoclonal antibody (mAB) within 5 half-lives or within 6 months before V1 if the half-life is unknown. Anti-immunoglobulin E (IgE) therapy ...

10. Brain Metastases Clinical Trials - Mayo Clinic Research

    Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...